Autopsy report · NCT01051401

Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“slow accrual”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 4 years before it stopped.
5 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Wake Forest University Health Sciences
Sponsor type: University, hospital or other
Conditions: Cardiovascular Complications; Recurrent Breast Cancer; Stage I Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer
Interventions: rosuvastatin; placebo; survey administration; management of therapy complications
Participants: 5
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.